ProShare Advisors’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-13,716
| Closed | -$727K | – | 2112 |
|
|
2024
Q2 | $727K | Sell |
13,716
-4,686
| -25% | -$248K | ﹤0.01% | 821 |
|
|
2024
Q1 | $1.51M | Buy |
18,402
+2,487
| +16% | +$204K | ﹤0.01% | 708 |
|
|
2023
Q4 | $296K | Buy |
15,915
+3,424
| +27% | +$63.7K | ﹤0.01% | 1392 |
|
|
2023
Q3 | $138K | Sell |
12,491
-14
| -0.1% | -$155 | ﹤0.01% | 1568 |
|
|
2023
Q2 | $203K | Buy |
+12,505
| New | +$203K | ﹤0.01% | 1533 |
|
|
2022
Q2 | – | Sell |
-12,825
| Closed | -$39K | – | 2140 |
|
|
2022
Q1 | $39K | Sell |
12,825
-2,122
| -14% | -$6.45K | ﹤0.01% | 2130 |
|
|
2021
Q4 | $69K | Buy |
+14,947
| New | +$69K | ﹤0.01% | 2245 |
|
|
2021
Q3 | – | Sell |
-17,747
| Closed | -$106K | – | 2279 |
|
|
2021
Q2 | $106K | Buy |
17,747
+223
| +1% | +$1.33K | ﹤0.01% | 2284 |
|
|
2021
Q1 | $111K | Buy |
17,524
+2,998
| +21% | +$19K | ﹤0.01% | 2153 |
|
|
2020
Q4 | $82K | Buy |
+14,526
| New | +$82K | ﹤0.01% | 2012 |
|